Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  In Vivo

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 17708367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Lipoprotein (a) and stroke].

  2008cited by this paper
• Fibrinogen: a predictor of vascular disease.

  2007cited by this paper
• The Relationship Between Circulating Fibrinogen and Lipoprotein (a) Levels in Patients With Primary Dyslipidemia

  2007cited by this paper
• Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study

  2006cited by this paper
• Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study

  2006cited by this paper
• Dyslipidaemia, hypercoagulability and the metabolic syndrome.

  2006cited by this paper
• Dyslipidemia in chronic kidney disease: Causes and consequences

  2006cited by this paper
• Prognostic value of serum albumin combined with serum C-reactive protein levels in older hospitalized patients: continuing importance of serum albumin

  2006cited by this paper
• Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.

  2006cited by this paper
• Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam.

  2006cited by this paper
• New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)

  2005cited by this paper
• Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.

  2005cited by this paper
• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  2005cited by this paper
• Lipoprotein(a): an elusive cardiovascular risk factor.

  2004cited by this paper
• Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease.

  2004cited by this paper
• Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking.

  2004cited by this paper
• Effects of fenofibrate on lipoproteins, vasomotor function, and serological markers of inflammation, plaque stabilization, and hemostasis.

  2004cited by this paper
• Hypothyroidism and dyslipidemia: Modern concepts and approaches

  2004cited by this paper
• Serum bilirubin levels in the U.S. Population: Gender effect and inverse correlation with colorectal cancer

  2004cited by this paper
• Preventive cardiology: abstractLp (a) lipoprotein, vascular disease and mortality in the elderly

  2004cited by this paper
• Lp(a) lipoprotein, vascular disease, and mortality in the elderly.

  2003cited by this paper
• Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study).

  2003cited by this paper
• Serum Albumin and Risk of Myocardial Infarction and All-Cause Mortality in the Framingham Offspring Study

  2002cited by this paper
• Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.

  2002cited by this paper
• Menopause and ischaemic stroke: basic, clinical and epidemiological considerations. The role of hormone replacement.

  2002cited by this paper
• The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin.

  2002cited by this paper
• A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment?

  2002cited by this paper
• Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study.

  2001cited by this paper
• Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study.

  2001cited by this paper
• Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes.

  2001cited by this paper
• A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.

  2001cited by this paper
• Association of serum bilirubin concentration with risk of coronary artery disease.

  2000cited by this paper
• Lipoprotein (a) and stroke

  2000cited by this paper
• The Effect of Atorvastatin on Serum Lipids, Lipoprotein(a) and Plasma Fibrinogen Levels in Primary Dyslipidaemia – A Pilot Study Involving Serial Sampling

  2000cited by this paper
• Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

  2000cited by this paper
• Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

  2000cited by this paper
• Bilirubin and peripheral vascular disease

  2000cited by this paper
• [Hemostasis and atherosclerosis].

  2000cited by this paper
• Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia.

  1999cited by this paper
• Bilirubin and peripheral vascular disease

  1999cited by this paper
• Risk factors for coronary heart disease and acute-phase proteins. A population-based study.

  1999cited by this paper
• Lipoprotein (a) in android obesity and NIDDM: a new member in 'the metabolic syndrome'.

  1999cited by this paper
• Statins and fibrinogen.

  1998cited by this paper
• Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

  1998cited by this paper
• 'Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension'.

  1998cited by this paper
• Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

  1998cited by this paper
• Effect of atorvastatin on plasma fibrinogen.

  1998cited by this paper
• Association of smoking and low serum bilirubin antioxidant concentrations.

  1998cited by this paper
• Statins and fibrinogen.

  1998cited by this paper
• Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension.

  1998cited by this paper
• Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.

  1997cited by this paper
• Association of serum albumin and mortality risk.

  1997cited by this paper
• Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men.

  1997cited by this paper
• Albumin as a predictor of mortality in elderly patients.

  1997cited by this paper
• New and classical risk factors--the Münster heart study (PROCAM).

  1997cited by this paper
• Oral 17β-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women1

  1997cited by this paper
• Serum Albumin, Coronary Heart Disease Risk, and Mortality in an Elderly Cohort

  1997cited by this paper
• Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults.

  1997cited by this paper
• Relationship between bilirubin, apolipoprotein B, and coronary artery disease.

  1997cited by this paper
• Serum Bilirubin and Cardiovascular Risk Factors in a Chinese Population

  1996cited by this paper
• Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase.

  1996cited by this paper
• Plasma albumin and platelet function: relevance to atherogenesis and thrombosis.

  1996cited by this paper
• Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group.

  1996cited by this paper
• Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.

  1996cited by this paper
• Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene.

  1996cited by this paper
• Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).

  1996cited by this paper
• An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.

  1996cited by this paper
• Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.

  1996cited by this paper
• Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees.

  1996cited by this paper
• Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons.

  1996cited by this paper
• Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The Study of Men Born in 1933

  1996cited by this paper
• Hemostasis and atherosclerosis.

  1995cited by this paper
• Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.

  1995cited by this paper
• Serum bilirubin and risk of ischemic heart disease in middle-aged British men.

  1995cited by this paper
• Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin.

  1995cited by this paper
• Fibrinogen and Cardiovascular Risk

  1995cited by this paper
• Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.

  1995cited by this paper
• Serum albumin and mortality in the BUPA study. British United Provident Association.

  1994cited by this paper
• Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.

  1994cited by this paper
• Association of low serum concentration of bilirubin with increased risk of coronary artery disease.

  1994cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease.

  1994cited by this paper
• Serum albumin level and physical disability as predictors of mortality in older persons.

  1994cited by this paper
• Secondary causes of hyperlipidemia.

  1994cited by this paper
• Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study.

  1994cited by this paper
• Is bilirubin protective against coronary artery disease?

  1994cited by this paper
• Comparison of the lysine binding functions of lipoprotein(a) and plasminogen.

  1993cited by this paper
• Lipoprotein (a) in a randomly selected 25-64 year old population: the Northern Sweden Monica Study.

  1993cited by this paper
• Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

  1993cited by this paper
• Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

  1993cited by this paper
• Lipoprotein[a] as a risk factor for preclinical atherosclerosis.

  1993cited by this paper
• Serum albumin, coronary heart disease, and death.

  1992cited by this paper
• Fibrinogen, a cardiovascular risk factor

  1992cited by this paper
• The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.

  1991cited by this paper
• Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population.

  1991cited by this paper
• Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes.

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study

  1986cited by this paper
• Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

  1985cited by this paper

• C-Reactive Protein to Albumin Ratio Predict In-Hospital and Long-term Outcome of ST-Segment-Elevation Myocardial Infarction Patients with SARS-CoV2 Infection Underwent Fibrinolytic Therapy.

  2022cites this paper
• The Relation Between C-Reactive Protein–Albumin Ratio and Carotid Intima-Media Thickness in Psoriasis

  2022cites this paper
• Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension?

  2021cites this paper
• Relation Between Globulin, Fibrinogen, and Albumin With the Presence and Severity of Coronary Artery Disease

  2020cites this paper
• Refinement of a Methodology for Untargeted Detection of Serum Albumin Adducts in Human Populations

  2017cites this paper
• Evaluation of occupational exposure to metal dust on the liver of road construction workers in Abuja metropolis

  2017cites this paper
• Does bilirubin protect against developing diabetes mellitus?

  2016cites this paper
• Testing Clinical Scores to Diagnose Incident Deep Vein Thrombosis in Patients Hospitalized in a Department of Medicine

  2016cites this paper
• Serum Albumin Levels on Admission Are Associated With Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

  2015cites this paper
• Where Are We Now With Bilirubin as a Marker of Vascular Risk?

  2014cites this paper
• Letter to the Editor

  2014cites this paper
• Serum Bilirubin Level and Aortic Intima–Media Thickness in Patients Without Clinical Manifestation of Atherosclerotic Cardiovascular Disease

  2014influential citation
• Value of Albumin–Globulin Ratio as a Predictor of All-Cause Mortality After Non-ST Elevation Myocardial Infarction

  2013cites this paper
• Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans.

  2012cites this paper
• Serum albumin is a useful prognostic indicator and adds important information to NT-proBNP in a Chinese cohort of heart failure.

  2012cites this paper
• Potential prevention of thromboembolism by genetic counseling and testing for two common thrombophilia mutations.

  2012cites this paper
• Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target?

  2011cites this paper
• Free-floating thrombus in the internal carotid artery: diagnosis and treatment of 16 cases in a single center.

  2011cites this paper
• Thrombus libre flottant de l'artère carotide interne : Diagnostic et traitement de 16 cas dans un centre

  2011cites this paper
• Diabetes and antioxidants: myth or reality?

  2010cites this paper
• Associations of Thrombotic-Hemostatic Factors with Cardiovascular Disease~!2009-10-29~!2009-12-22~!2010-04-08~!

  2010cites this paper
• Nephroprotective and clinical potential of statins in dialyzed patients.

  2009cites this paper
• Bilirubin and peripheral arterial disease: 15 years later

  2009cites this paper
• Nephroprotective and clinical potential of statins in dialyzed patients

  2009cites this paper
• Lipoprotein a: where are we now?

  2009cites this paper
• Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia

  2009cites this paper
• Nephroprotectiveandclinical potentialofstatinsin dialyzedpatients

  2009cites this paper
• Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence: A Prospective Study in Korean Men and Women

  2009cites this paper
• ST SEGMENT RESOLUTION IN OPIUM ADDICT PATIENTS AFTER THROMBOLYTIC THERAPY ACUTE MYOCARDIAL INFARCTION

  2008cites this paper
• NutriGeneOntology: A Biomedical Ontology for Nutrigenomics Research

  2008cites this paper
• Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

  2008cites this paper
• BOGENVI: A Biomedical Ontology for Modelling Gene*Environment Interactions on Intermediate Phenotypes in Nutrigenomics Research

  2008cites this paper
• Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease

  2007cites this paper